Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
National HealthCare Co. stock logo
NHC
National HealthCare
$104.86
-1.1%
$100.41
$89.14
$138.49
$1.62B0.5558,686 shs271,511 shs
PACS Group, Inc. stock logo
PACS
PACS Group
$13.25
-0.4%
$10.16
$8.28
$43.92
$2.03B0.21814,713 shs1.44 million shs
Progyny, Inc. stock logo
PGNY
Progyny
$20.98
-3.1%
$21.87
$13.39
$30.42
$1.86B1.321.71 million shs1.75 million shs
Personalis, Inc. stock logo
PSNL
Personalis
$6.42
-1.7%
$4.70
$1.14
$7.20
$576.76M1.861.07 million shs2.02 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
National HealthCare Co. stock logo
NHC
National HealthCare
-1.11%+1.71%+1.53%+15.59%-0.93%
PACS Group, Inc. stock logo
PACS
PACS Group
-0.70%+27.77%+33.77%+14.88%-55.40%
Progyny, Inc. stock logo
PGNY
Progyny
-3.09%-0.24%-0.99%-4.03%-18.46%
Personalis, Inc. stock logo
PSNL
Personalis
-1.68%+6.82%+36.02%+80.34%+409.52%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
PACS Group, Inc. stock logo
PACS
PACS Group
2.664 of 5 stars
3.41.00.00.01.80.01.9
Progyny, Inc. stock logo
PGNY
Progyny
1.6451 of 5 stars
2.21.00.00.02.72.51.3
Personalis, Inc. stock logo
PSNL
Personalis
3.9447 of 5 stars
2.53.00.04.23.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
PACS Group, Inc. stock logo
PACS
PACS Group
2.86
Moderate Buy$34.29158.76% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.4511.79% Upside
Personalis, Inc. stock logo
PSNL
Personalis
3.00
Buy$7.6719.42% Upside

Current Analyst Ratings Breakdown

Latest PSNL, PGNY, NHC, and PACS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
Personalis, Inc. stock logo
PSNL
Personalis
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$6.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/7/2025
Personalis, Inc. stock logo
PSNL
Personalis
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $9.00
4/10/2025
Personalis, Inc. stock logo
PSNL
Personalis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
3/31/2025
Progyny, Inc. stock logo
PGNY
Progyny
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$28.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
National HealthCare Co. stock logo
NHC
National HealthCare
$1.37B1.18$6.69 per share15.68$59.41 per share1.77
PACS Group, Inc. stock logo
PACS
PACS Group
$3.11B0.65N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.54$0.33 per share62.74$4.96 per share4.23
Personalis, Inc. stock logo
PSNL
Personalis
$84.61M6.70N/AN/A$2.87 per share2.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.9213.14N/A10.03%6.87%4.68%N/A
PACS Group, Inc. stock logo
PACS
PACS Group
$112.87MN/A0.007.44N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5736.8132.282.284.33%10.90%7.20%8/5/2025 (Estimated)
Personalis, Inc. stock logo
PSNL
Personalis
-$81.28M-$1.29N/AN/AN/A-98.10%-48.78%-34.70%8/6/2025 (Estimated)

Latest PSNL, PGNY, NHC, and PACS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
5/6/2025Q1 2025
Personalis, Inc. stock logo
PSNL
Personalis
-$0.23-$0.18+$0.05-$0.18$17.41 million$20.61 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
National HealthCare Co. stock logo
NHC
National HealthCare
$2.562.44%N/A36.99%10 Years
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Personalis, Inc. stock logo
PSNL
Personalis
N/AN/AN/AN/AN/A

Latest PSNL, PGNY, NHC, and PACS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.642.7%6/30/20256/30/20258/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.39
2.39
Personalis, Inc. stock logo
PSNL
Personalis
N/A
6.91
6.74

Institutional Ownership

CompanyInstitutional Ownership
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Personalis, Inc. stock logo
PSNL
Personalis
61.91%

Insider Ownership

CompanyInsider Ownership
National HealthCare Co. stock logo
NHC
National HealthCare
14.97%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Personalis, Inc. stock logo
PSNL
Personalis
3.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.46 million13.32 millionN/A
PACS Group, Inc. stock logo
PACS
PACS Group
32,433152.40 millionN/AOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million77.66 millionOptionable
Personalis, Inc. stock logo
PSNL
Personalis
40088.32 million84.97 millionOptionable

Recent News About These Companies

Personalis, Inc. stock logo
Personalis (NASDAQ:PSNL) Shares Up 7% - Should You Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

National HealthCare stock logo

National HealthCare NYSE:NHC

$104.86 -1.18 (-1.11%)
As of 06/20/2025 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

PACS Group stock logo

PACS Group NYSE:PACS

$13.25 -0.05 (-0.38%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$13.19 -0.06 (-0.45%)
As of 06/20/2025 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Progyny stock logo

Progyny NASDAQ:PGNY

$20.98 -0.67 (-3.09%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$20.96 -0.02 (-0.10%)
As of 06/20/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Personalis stock logo

Personalis NASDAQ:PSNL

$6.42 -0.11 (-1.68%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$6.44 +0.01 (+0.23%)
As of 06/20/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.